Both in Pharmaceuticals
Milestone Pharmaceuticals vs PDS Biotechnology
Over the past year MIST returned −58.0% and PDSB returned +46.3%; their daily moves had a correlation of 0.17.
MIST −58.0% PDSB +46.3%Growth of $1, one year, split-adjusted
| Metric | MIST | PDSB |
|---|---|---|
| Price | $0.7725 | $1.30 |
| Market cap | $96.2M | $94.2M |
| Today | +1.74% | −7.80% |
| 1 month | +1.1% | +24.4% |
| 6 months | −60.8% | +22.6% |
| Year to date | −61.8% | +68.9% |
| 1 year | −58.2% | +39.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | 94.3% | — |
| Net margin | −5118.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 41.0× | — |
| Net cash | $111.4M | $1.2M |
| Dividend yield | — | — |
| Volatility (60d) | 74.2% | 228.8% |
| Short % of float | 17.9% | 8.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).